SymbolATLN
NameATLANTIC INTERNATIONAL CORP.
SectorINDUSTRIALS
RegionNorth America
Industry-
Address07632 United States NJ 270 Sylvan Avenue Suite 2230
Telephone(201) 899-4470
Fax
Email
Websitehttps://seqll.com/
IncorporationUS
Incorporated On
Employees
Fiscal Year12/31
Public Since
ExchangesOTC;NASDAQ
AuditorRBSM LLP;
Audit StatusAUDITED
Reporting StatusU.S. Reporting: SEC Reporting
CIK0001605888
Description

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The companys True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justices Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support.

Additional info from NASDAQ:
Atlantic International Corp., formerly SeqLL Inc., is a strategic staffing, outsourced services, and workforce solutions company. The Company is engaged in servicing the light industrial, commercial, professional, finance, direct placement, and managed service provider verticals, according to Staffing Industry Analysts. It provides its customers with complete HR solutions, operating 40 independent on-site and vendor-on-premises facilities. Its core offerings include staffing and recruitment, program management, data mastery and continuous refinement. Staffing and recruitment offer pioneering client-centric forecasting and staffing solutions. Program management is a bespoke program ensuring longevity and growth in client partnerships. Data mastery is a database solution to monitor usage and pivotal data points.

Additional info from OTC:
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The companys True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justices Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support.

2026-04-08 09:45

New Form 424B3 - ATLANTIC INTERNATIONAL CORP. <b>Filed:</b> 2026-04-08 <b>AccNo:</b> 0001213900-26-041282 <b>Size:</b> 437 KB

Read more
2026-04-02 17:06

New Form 424B3 - ATLANTIC INTERNATIONAL CORP. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001213900-26-039326 <b>Size:</b> 407 KB

Read more
2026-04-01 10:01

New Form NT 10-K - ATLANTIC INTERNATIONAL CORP. <b>Filed:</b> 2026-04-01 <b>AccNo:</b> 0001605888-26-000009 <b>Size:</b> 29 KB

Read more
2026-03-26 21:00

(99% Neutral) ATLANTIC INTERNATIONAL CORP. (ATLN) Announces Business Combination

Read more
2026-03-24 17:19

New Form DEL AM - ATLANTIC INTERNATIONAL CORP. <b>Filed:</b> 2026-03-24 <b>AccNo:</b> 0001213900-26-033548 <b>Size:</b> 8 KB

Read more
2026-03-16 12:30

Atlantic International to Attend 38th Annual ROTH Conference

Read more